503559-84-0,
1-(4-(2-(Benzyloxy)-4-fluorophenyl)-2,6-diisopropyl-5-(prop-1-en-1-yl)pyridin-3-yl)ethanol,
glucagon receptor antagonists-1,
C29H34FNO2,
4-[4-Fluoro-2-(phenylmethoxy)phenyl]-alpha-methyl-2,6-bis(1-methylethyl)-5-(1-propen-1-yl)-3-pyridinemethanol,
6910AB,
AKOS016005224,
CS-0301,
ACM503559840,
HY-10036,
AX8234875,
TC-153634,
W-5587,
559P840,
3-Pyridinemethanol, 4-[4-fluoro-2-(phenylmethoxy)phenyl]-alpha-methyl-2,6-bis(1-methylethyl)-5-(1-propen-1-yl)-,
alpha-Methyl-2,6-diisopropyl-4-[2-(benzyloxy)-4-fluorophenyl]-5-(1-propenyl)pyridine-3-methanol,
glucagon receptor antagonists 1,
(E)-1-(4-(2-(Benzyloxy)-4-fluorophenyl)-2,6-diisopropyl-5-(prop-1-en-1-yl)pyridin-3-yl)ethanol,
4-[4-Fluoro-2-(phenylmethoxy)phenyl]-?-methyl-2,6-bis(1-methylethyl)-5-(1-propen-1-yl)-3-pyridinemethanol,